Updates are available Correction dated 2024-12-09
Click to view Correction: https://doi.org/10.1038/s41584-024-01203-8
-
Authors
Lichtnekert, Julia
Anders, Hans-Joachim https://orcid.org/0000-0003-2434-2956
- License Information
-
More Information
Article History
Accepted: 14 August 2024
First Online: 24 September 2024
Change Date: 9 December 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41584-024-01203-8
Competing interests
: H.-J.A. has received consultancy and lecture fees from Otsuka, GSK, AstraZeneca, Bayer, Boehringer Ingelheim, Roche, Novartis and SOBI. J.L. declares no competing interests.
